Clinical Trial Update: A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial comparing pharmacokinetics of subcutaneous vedolizumab delivered via prefilled syringe vs syringe with needle safety device in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-08-12